India Witnesses Reduction in Drug-Resistant TB Cases

India has scaled up the availability of molecular diagnostic facilities. This effort has resulted in an increased proportion of TB patients being screened for the presence of drug resistance. Under the National TB Elimination Programme (NTEP), there has also been a consistent and regular supply of Anti-TB drugs to all states and union territories (UTs) throughout the year.

WHO acknowledges India’s Success in the TB Report 2023

The report applauds India’s efforts, resulting in a 16% reduction in TB incidence in 2022, outpacing the global decline rate. TB mortality has also seen an 18% decrease both in India and globally, leading to a significant downward revision in mortality rates.

MoHFW organises Swasthya Chintan Shivir

The aim of the event was to achieve last-mile connectivity in health services. The participants have engaged in comprehensive discussions on the current state of the health sector in India and the path forward to ensure universal health coverage.

ICMR holds Innovative TB Health Technologies Workshop

The two-day workshop aims to promote innovative health technologies for tuberculosis (TB) and facilitate their adoption in the End TB program. It also serves as a platform to showcase TB innovation health technologies exhibited at the Stop TB Summit in Varanasi.